Differences in neurohormonal activity partially explain the obesity paradox in patients with heart failure: The role of sympathetic activation

International Journal of Cardiology

Volumn 181, Issue , 2015, Pages 120-126

  Farré, Núria ^a,b   Aranyó, Júlia ^a,c,d   Enjuanes, Cristina ^a,b,c,d   Verdú Rotellar, José María ^b,c,d,e   Ruiz, Sonia ^a,b   Gonzalez Robledo, Gina ^a,b   Meroño, Oona ^a,b   De Ramon, Marta ^f   Moliner, Pedro ^a,b,c,d   Bruguera, Jordi ^a,b   Comin Colet, Josep ^a,b,c,d  

^a Program on Research on Inflammatory and Cardiovascular Disorders (RICAD)   (Spain)

^b HOSPITAL DEL MAR   (Spain)

^c UNIVERSITAT POMPEU FABRA   (Spain)

^d UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^e Jordi Gol Primary Care Research Institute   (Spain)

^f Laboratorio de Referencia de Catalunya   (Spain)

Author keywords

Body mass index; Chronic heart failure; Norepinephrine; Obesity

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; NEUROHORMONE; NORADRENALIN;

AGED; ARTICLE; BODY MASS; BODY WEIGHT; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HORMONE ACTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OBESITY; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; SYMPATHETIC TONE; ADRENERGIC SYSTEM; CHRONIC DISEASE; METABOLISM; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; SPAIN; SURVIVAL; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BODY MASS INDEX; CHRONIC DISEASE; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NOREPINEPHRINE; OBESITY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SPAIN; SURVIVAL ANALYSIS; SYMPATHETIC NERVOUS SYSTEM;

EID: 84947201415     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.12.025     Document Type: Article

References (27)

1. C.J. Lavie, R.V. Milani, and H.O. Ventura Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss J. Am. Coll. Cardiol. 53 21 2009 1925 1932
2. A.L. Clark, G.C. Fonarow, and T.B. Horwich Obesity and the obesity paradox in heart failure Prog. Cardiovasc. Dis. 56 4 2014 409 414
3. C.J. Lavie, M.A. Alpert, R. Arena, M.R. Mehra, R.V. Milani, and H.O. Ventura Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure JACC Heart Fail. 1 2 2013 93 102
4. R.W. Schrier, and W.T. Abraham Hormones and hemodynamics in heart failure N. Engl. J. Med. 341 8 1999 577 585
5. F. Triposkiadis, G. Karayannis, G. Giamouzis, J. Skoularigis, G. Louridas, and J. Butler The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications J. Am. Coll. Cardiol. 54 19 2009 1747 1762
6. J.J.V. McMurray, S. Adamopoulos, and S.D. Anker ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology Eur. Heart J. 33 14 2012 Jul 1787 1847
7. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee World Health Organ. Tech. Rep. Ser. 854 1995 1 452
8. W. Geneva Health Organization 2011 (WHO/NMH/NHD/MNM/11.1). WHO. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and Mineral Nutrition Information, System Available from: http://www.who.int/vmnis/indicators/haemoglobin 2011
9. A.S. Levey, J.P. Bosch, and J.B. Lewis A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation Ann. Intern. Med. 130 1999 461 470
10. J. Curtis, J. Selter, and Y. Wang The obesity paradox Arch. Intern. Med. 165 2005 55 61
11. G.C. Fonarow, P. Srikanthan, M.R. Costanzo, G.B. Cintron, and M. Lopatin An obesity paradox in acute heart failure: analysis of body mass index and in hospital mortality for 108,927 patients in the Acute Decompensated Heart Failure National Registry Am. Heart J. 153 1 2007 74 81
12. A.L. Clark, J. Chyu, and T.B. Horwich The obesity paradox in men versus women with systolic heart failure Am. J. Cardiol. 110 1 2012 77 82
13. A. Oreopoulos, R. Padwal, K. Kalantar-Zadeh, G.C. Fonarow, C.M. Norris, and F.A. McAlister Body mass index and mortality in heart failure: a meta-analysis Am. Heart J. 156 1 2008 Jul 13 22
14. R. Padwal, F. a McAlister, and J.J.V. McMurray The obesity paradox in heart failure patients with preserved versus reduced ejection fraction: a meta-analysis of individual patient data Int. J. Obes. (Lond.) 38 8 2014 1110 1114
15. J. Cohn, T. Levine, and M. Olivari Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure N. Engl. J. Med. 311 1984 819 823
16. C. Benedict, B. Shelton, and D. Johnstone Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction Circulation 94 1996 690 697
17. K. Yufu, N. Okada, and Y. Ebata Plasma norepinephrine is an independent predictor of adverse cerebral and cardiovascular events in type 2 diabetic patients without structural heart disease J. Cardiol. 64 3 2014 225 230
18. K.P. Davy, and J.S. Orr Sympathetic nervous system behavior in human obesity Neurosci. Biobehav. Rev. 33 2 2009 116 124
19. M. Vaz, G. Jennings, A. Turner, H. Cox, G. Lambert, and M. Esler Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects Circulation 96 1997 3423 3429
20. N. Tentolouris, S. Liatis, and N. Katsilambros Sympathetic system activity in obesity and metabolic syndrome Ann. N. Y. Acad. Sci. 1083 2006 129 152
21. T.B. Horwich, M.A. Hamilton, and G.C. Fonarow B-type natriuretic peptide levels in obese patients with advanced heart failure J. Am. Coll. Cardiol. 47 1 2006 85 90
22. A. Clerico, A. Giannoni, S. Vittorini, and M. Emdin The paradox of low BNP levels in obesity Heart Fail. Rev. 17 1 2012 81 96
23. S.A. Morse, P.E. Bravo, M.C. Morse, and E. Reisin The heart in obesity-hypertension Expert. Rev. Cardiovasc. Ther. 3 4 2005 647 658
24. M. Lafontan, C. Moro, C. Sengenes, J. Galitzky, F. Crampes, and M. Berlan An unsuspected metabolic role for atrial natriuretic peptides: the control of lipolysis, lipid mobilization, and systemic nonesterified fatty acids levels in humans Arterioscler. Thromb. Vasc. Biol. 25 10 2005 2032 2042
25. C. Sengenes, C. Moro, J. Galitzky, M. Berlan, and M. Lafontan Natriuretic peptides: a new lipolytic pathway in human fat cells Med. Sci. (Paris) 21 Spec No 2005 29 33
26. R. Sarzani, F. Salvi, P. Dessi-Fulgheri, and A. Rappelli Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans J. Hypertens. 26 2008 831 843
27. T. Tsutamoto, K. Nishiyama, and H. Sakai Transcardiac increase in norepinephrine and prognosis in patients with chronic heart failure Eur. J. Heart Fail. 10 12 2008 1208 1214